• Title: SMISS Research Updates: Clinical Outcomes: Part 1
  • Release date: April 2020
  • Expiration date: April 2022
  • Estimated time to complete activity: 0.5 hours
    • Hardware and Software Requirements
      • Windows 8, or 10 with Internet Explorer 11 or later
      • Latest version of Edge browser
      • Latest version of Firefox
      • Latest version of Chrome
      • Mac OSX with latest version of Safari
      • High-speed internet connection required
    • For information about the accreditation of this program, please contact Medical Education Resources (MER) at 800-421-3756 or info@mer.org.
    • MER Privacy Policy [Click Here]
    • This activity is jointly provided by Medical Education Resources and the Society for Minimally Invasive Spine Surgery.

Target Audience

This activity has been designed to meet the educational needs of orthopaedic and neurologic surgeons, fellow, residents and allied health professionals involved in the care of patients with spinal conditions.

Statement of Need/Program Overview

To enable surgeons, fellows, residents and allied health professionals involved with minimally invasive spine surgery to gain knowledge about research results in the field.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Describe the results of research presented addressing minimally invasive spine surgery
  • Discuss the implications of the results of the research presented addressing minimally invasive spine surgery


Hyun Bae, MD

Cedars-Sinai Medical Center, Los Angeles, CA

Salah Aoun, MD

Nathaniel W. Jenkins, MS

Rush University Medical Center, Chicago, IL

John Chi, MD, MPH

Brigham and Women’s Hospital, Boston, MA

Program Agenda

  1. FDA Trial of Paraspinous Tension Band for Degenerative Spondylolisthesis: Preliminary Safety and Outcomes in 100 Subjects with 6-Months Follow-up
  2. Stem Cell Injections for Axial Back Pain: A Systematic Review of Associated Risks and Complications with Case Illustration of Diffuse Hyperplastic Gliosis Resulting in Cauda Equina Syndrome
  3. The Impact of Comorbidity Burden on Postoperative PROMIS Physical Function Following Minimally Invasive Transforaminal Lumbar Interbody Fusion
  4. Preliminary 24-month Outcomes of a Prospective Investigation of a Novel Mesh Interbody Spacer in Single-level Fusions

Physician Credit

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint provider-ship of Medical Education Resources (MER) and SMISS. MER is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Medical Education Resources designates this enduring material for a maximum of .50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:


Name of Faculty Reported Financial Relationship

Hyun Bae, MD

Grants/Research Support: Pfizer, Rebosis, Empirical Spine, Medtronic, Simplify Medical, Mesoblast

Consulting Fees: Stryker, K2M, DePuy Synthes, Prosidyan, NuVasive

Ownership Interest/Shareholder:Prosidyan, DiFusion, Stryker, NuVasive, Medtronic

Royalty/Patent Holder: Stryker, K2M, NuVasive, DePuy Synthes, Zimmer Biomet, Prosidyan

Salah Aoun, MD None

Nathaniel W. Jenkins, MS



John Chi, MD, MPH Consulting Fees: Stryker K2M

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Name of Content Manager Reported Financial Relationship
SMISS No financial relationships to disclose
Planners at Medical Education Resources No financial relationships to disclose

Method of Participation

There are no fees for SMISS members to participate in and receive credit for this activity. Non-members will be charged $35.00 USD during the period April 2020 through April 2022. Participants must 1) read the CME front matter, 2) study the educational activity, 3) complete the posttest with a score of 70% or better, 4) complete the evaluation form, and 5) download CME certificate.




The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources orSMISS. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

MER Privacy Policy

Enroll in this Course by clicking on the "Enroll" button.